NR 293 DETAILED EXAM 1 2025
Drug - -Any chemical that affects the physiologic processes of a living organism
Pharmacology - -The study or science of drugs
Chemical Name - -Describes the drug's chemical composition and molecular structure
(not usually used in nursing)
Generic Name - -Name given by the United States Adopted Names council. The
universal name, like ibuprofen or acetaminophen
Trade Name - -AKA proprietary name. The drug has a registered trademark, use of the
name is restricted by the drug's patent owner. Ex is Motrin and Advil, they are both
ibuprofen
Pharmaceutics - -The study of how various drug forms influence the way in which the
drug affects the body.
Oral, rectal, transdermal, etc.
Pharmacodynamics - -The study of what the drug does to the body. The mechanism of
drug actions in living tissues and drug-receptor relationships
Pharmacotherapeutics - -The clinical use of drugs to prevent and treat disease. Defines
principles of drug actions- the cellular processes that change in response to the
presence of drug molecules. Drugs are organized into pharmacologic classes, like
antihypertensives.
Ex: elderly taking baby aspirin to prevent strokes
Pharmacognosy - -The study of natural drug sources, like plants, animals and minerals.
Pharmaceutic Properties - -Different drug dosage forms have different properties.
Dosage form determines the rate of drug dissolution. Enteric-coated tablets protect
patients from stomach irritation.
Fastest Route of Oral Drug Absorption - -1. Oral disintegration, buccal tabs, and oral
soluble wafers
2. Liquids, elixirs, and syrups
3. Suspension solutions
4. Powders
5. Capsules
6. Tablets
7. Coated tablets
NR293
, NR293
8. Enteric-coated tabletes
Pharmacokinetics - -The study of what the body does to the drug. A drug's time to onset
of action, time to peak effect, and duration of action.
-Absorption, Distribution, Metabolism, Excretion
Pharmacokinetics: Absorption - -Movement of a drug from its site of administration into
the bloodstream for distribution to the tissues.
Bioavailability - -A measure of the extent of drug absorption for a given drug and route.
Giving a med through the IV, you will have 100% of the med in the bloodstream, none is
lost.
First-Pass Effect - -The initial metabolism in the liver of a drug absorbed from the GI
tract before the drug reaches systemic circulation. If you give a PO med, the GI system
digests, liver transforms, and then it reaches the bloodstream. Not 100% of the med
reaches the bloodstream, you lose some as it travels.
Enteral Route of Drug Administration - -The drug is absorbed into the systemic
circulation through the oral or gastric mucosa or the small intestine. Types of enteral are
oral, sublingual, buccal, and rectal.
Parenteral Route of Drug Administration - -Though an IV, IM, subcutaneous,
intradermal, intraarterial, intrathecal, and intraarticular
Topical Route of Drug Administration - -Skin, eyes, ears, nose, lungs, rectum, vagina
Pharmacokinetics: Distribution - -The transport of a drug by the bloodstream to its site of
action. Protein-binding, water-soluble vs fat-soluble, blood-brain barrier.
Protein-Binding Drugs - -After you take the medication, it is in the blood attached to
protein, mainly albumin. When the drug binds to albumin, it works as a slow release,
only the free unbound drug is therapeutic. The bound drug is essentially inactive. Type
of drugs that are protein-binding are blood thinners. If a patient is deficient in albumin,
there is a problem of too much free-drug.
Pharmacokinetics: Metabolism/Biotransformation - -The biochemical alteration of a drug
into an inactive metabolite, a more soluble compound, a more potent active metabolite,
or a less active metabolite. Transformed mainly in the liver, but also skeletal muscle,
kidneys, lungs, plasma, intestinal mucosa.
Factors the Decrease Metabolism - -Cardiovascular dysfunction, renal insufficiency,
starvation, obstructive jaundice, slow acetylator, and ketoconazole therapy
Factors the Increase Metabolism - -Fast acetylator, barbiturate therapy, rifampin
therapy, and phenytoin therapy
NR293